Clinical Trial Update: A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and effectiveness of efgartigimod in patients with Primary Sjögren's syndrome has completed and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Efgartigimod (efgartigimod)

Snippet

Sponsor: argenx | Conditions: Primary Sjögren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-07-18